Eiger BioPharmaceuticals, Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent history and growth rate from Q1 2019 to Q3 2023.
  • Eiger BioPharmaceuticals, Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending September 30, 2023 was 0.13 pure, a 43.7% increase year-over-year.
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 0.13 +0.04 +43.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 0.13 +0.04 +43.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 0.13 +0.04 +43.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 0.13 +0.04 +43.7% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 0.09 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 0.09 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 0.09 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 0.09 0 0% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 0.09 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 0.09 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 0.09 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 0.09 0 0% Dec 31, 2020 10-Q 2021-11-04
Q3 2020 0.09 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 0.09 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 0.09 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 0.09 Dec 31, 2019 10-Q 2020-11-05
Q3 2019 0.09 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 0.09 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 0.09 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.